PMM2 and infection: This means that, in a disease as PMM2-CDG, where hypoglycosylation is prevalent, the impaired general glycosylation caused by this defect early in the N-glycosylation pathway could compromise the effective recognition of threats by immune receptors and the overall immunological response in these patients, leading to a possibly higher susceptibility to recurrent and severe infections in PMM2-CDG patients.